Global Plastic Syringe Market to Reach USD 6.4 Billion by 2035, Driven by Safety, Innovation, and Expanding Healthcare Access

The global plastic syringe market is projected to expand from USD 3.9 billion in 2025 to USD 6.4 billion by 2035, registering a steady CAGR of 5% over the forecast period. Sales in 2024 stood at USD 3.7 billion, reflecting growing demand for disposable and safe injection systems amid rising global healthcare needs and expanding use of injectable therapies.

Rising Demand Driven by Safety and Convenience

The increasing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, is driving the need for regular injections and precise drug delivery systems. In addition, government vaccination programs and public health initiatives are fueling consistent demand for syringes globally.

Plastic syringes—primarily made from polypropylene (PP), polyethylene (PE), and polycarbonate (PC)—are gaining preference for their cost-efficiency, durability, and sterility. The market is segmented into hypodermic syringes, oral syringes, and prefilled syringes, with hypodermic syringes expected to dominate due to their wide medical application.

Unlock Growth Potential – Request Your Sample Now and Explore Market Opportunities! https://www.futuremarketinsights.com/reports/sample/rep-gb-9211

Innovation Spotlight: Gerresheimer’s Sustainable Expansion

A key development shaping the industry is Gerresheimer AG’s recent EUR 100 million investment in expanding and modernizing its Lohr manufacturing site. Dietmar Siemssen, CEO of Gerresheimer AG, commented,

“Our investments in cutting-edge production technology secure the future. With state-of-the-art facilities for high-value products, we are strengthening our competitiveness, securing long-term jobs, and advancing our sustainability goals.”

This expansion reflects a broader industry trend of investing in automated, sustainable, and high-quality syringe production to meet growing global healthcare demands.

Market Segmentation: Hypodermic and Insulin Syringes Take the Lead

Hypodermic Syringes – Precision and Utility

Holding a commanding 58% market share in 2025, hypodermic syringes continue to dominate due to their essential role in administering vaccines, medications, and diagnostic fluids. These syringes offer sterility, disposability, and safety, helping minimize cross-contamination in medical settings. Regulatory agencies across the U.S. and Europe are emphasizing safety-engineered and auto-disable syringes to prevent needle-stick injuries and ensure one-time usage.

Insulin Syringes – Empowering Self-Administration

Insulin syringes are projected to account for 29% of the market by 2025, fueled by the growing diabetic population and the rise in self-administered insulin therapy. With features like fine needles, clear dosage markings, and low dead space, these syringes ensure precision and comfort. While insulin pens and pumps are gaining traction, insulin syringes remain dominant in emerging economies due to their affordability and reliability.

Market Drivers

• Rising Chronic Disease Burden: Increasing global cases of diabetes, cancer, and cardiovascular diseases continue to boost syringe demand.
• Growth of Vaccination Programs: Global immunization campaigns and pandemic preparedness have accelerated syringe production.
• Shift Toward Disposable Devices: The healthcare industry’s move toward single-use syringes enhances infection control and patient safety.
• Technological Advancements: Safety syringes with retractable needles and smart syringe designs with dose-tracking features are reshaping patient care.

Challenges

• Environmental Concerns: The disposal of millions of plastic syringes daily contributes to medical waste pollution, prompting a need for recyclable materials and eco-friendly designs.
• High Cost of Advanced Syringes: Although safety and smart syringes enhance patient safety, their higher costs limit adoption in price-sensitive regions.

Key Trend Highlight – Safety Syringes on the Rise

Safety syringes with retractable needles are becoming the global standard, especially in developed markets such as the U.S., UK, and Germany. These devices prevent accidental needle-stick injuries and reduce reuse risks. Hospitals are increasingly adopting these syringes to comply with stringent worker safety and infection control regulations.

Purchase Full Report for Detailed Insights

For access to full forecasts, regional breakouts, company share analysis, and emerging trend assessments, you can purchase the complete report here:

Buy Full Report – https://www.futuremarketinsights.com/checkout/9211

Emerging Startups Shaping the Market

• Retrago: Focuses on automatic retractable syringes for improved safety.
• Apiject Systems Corp.: Specializes in blow-fill-seal (BFS) technology for single-use, prefilled plastic syringes used in vaccination drives.
• Credence MedSystems: Develops self-retracting syringes and partners with pharmaceutical companies for integrated drug delivery systems.

Why FMI: https://www.futuremarketinsights.com/why-fmi

Have a Look at Related Research Reports on the Packaging Domain:

Plastic Sterilization Trays Market https://www.futuremarketinsights.com/reports/plastic-sterilization-trays-market

Slotted Containers Market https://www.futuremarketinsights.com/reports/slotted-containers-market

Screw Top Jar Market https://www.futuremarketinsights.com/reports/screw-top-jar-market

Non-UV Dicing Tapes Market https://www.futuremarketinsights.com/reports/non-uv-dicing-tapes-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.